Recombinant Human RBL2 Protein ，His

RBL2, also known as Retinoblastoma-like protein 2, is a critical member of the retinoblastoma family of proteins, which play essential roles in cell cycle regulation and tumor suppression. Research into RBL2 has garnered significant interest due to its involvement in various cellular processes, including differentiation, apoptosis, and responses to DNA damage. Unlike its more famous counterpart, Rb1, which is often studied in the context of retinoblastoma and other cancers, RBL2 has been less characterized, though it is believed to have overlapping functionalities. The protein exhibits a high degree of conservation across species, indicating its fundamental role in maintaining cellular integrity. Studies have demonstrated that RBL2 can interact with numerous transcription factors and other signaling molecules, suggesting it may act as a crucial modulator of gene expression in response to cellular stress and proliferation signals. Furthermore, aberrations in RBL2 expression and function are linked to various malignancies, highlighting its potential as a therapeutic target. Recent advances in recombinant protein technology have enabled researchers to produce RBL2 in sufficient quantities for detailed functional studies, paving the way for further exploration of its biological roles and the mechanisms underlying its tumor-suppressive functions. Understanding RBL2's precise role in cellular processes could provide new insights into cancer biology and lead to the development of innovative strategies for cancer therapy. Thus, the research on RBL2 recombinant proteins not only enhances our molecular comprehension of this vital protein but also signifies its potential clinical relevance.